Journal article
Epinephrine autoinjectors: individualizing device and dosage to optimize anaphylaxis management in the community setting.
Abstract
Background: Anaphylaxis is the most severe manifestation of a systemic allergic reaction, and, in the community setting, the immediate administration of an epinephrine autoinjector (EAI) can be life-saving. Physicians are tasked with selecting the most appropriate EAI for each individual and counseling patients and/or their caregivers to maximize the likelihood of successful deployment of the EAI. Objective: To offer an evidence-based expert …
Authors
Kim H; Alizadehfar R; Alqurashi W; Ellis AK; Fischer DA; Roberts H; Torabi B; Waserman S
Journal
Allergy & Asthma Proceedings, Vol. 44, No. 1, pp. 45–50
Publisher
Oceanside Publications
Publication Date
January 1, 2023
DOI
10.2500/aap.2023.44.220073
ISSN
1088-5412